Ben Busby
dcgenomics.bsky.social
Ben Busby
@dcgenomics.bsky.social
Developing bioinformatics prototypes to push the envelope of what we can do with large pheno-geno (and now imaging) population and disease cohorts.
Reposted by Ben Busby
Our next roundtable covers the challenges & strategies for integrating vast, multi-modal datasets into their clinical testing workflows. hello.dnanexus.com/webinar/inno...
@dcgenomics.bsky.social @labcorp.bsky.social @premalshah.bsky.social h.bsky.social @myome.com
February 25, 2025 at 5:28 PM
Reposted by Ben Busby
📣 One week left for early bird registration and abstract submission for the 'Hidden Cell, Dark Genome' conference 3-4th April in Edinburgh. Regulatory functions of the dark genome, uncharted proteins & RNA complexity, cellular diversity, and atomic structures at the cellular scale 🧬! Join us #HCDG25
Hidden cell dark genome 2025
Hidden cell dark genome 2025
institute-genetics-cancer.ed.ac.uk
February 21, 2025 at 10:29 AM
Reposted by Ben Busby
@dcgenomics.bsky.social was on this week's @mendelspod.bsky.social! He discusses the genomic data ecosystem & the shift to #multiomics workflows incorporating #genomics, #proteomics, #imaging, and more. He also explores the impact of #AI in #bioinformatics. gw-resources.genomeweb.com/free/w_dnan1...
Toward Disease Sub-typing with Ben Busby, DNAnexus
We’re happy to welcome back Ben Busby, Principal Scientist at DNAnexus, to dive deeper into the evolving world of disease subtyping and multi-omic data sets.
gw-resources.genomeweb.com
February 14, 2025 at 4:29 PM
Reposted by Ben Busby
We’ve gathered an expert panel to discuss clinical testing innovations & how #diagnostics orgs can bridge the gap between research, #drugdevelopment, healthcare providers & patients. hello.dnanexus.com/webinar/inno...

@dcgenomics.bsky.social @labcorp.bsky.social @premalshah.bsky.social @myome.com
Innovations in Clinical Testing for Oncology & Rare Diseases
Clinical testing for oncology and rare diseases faces unique challenges that demand innovative solutions. Patient recruitment and retention remain significant hurdles, with stringent eligibility crite...
hello.dnanexus.com
February 20, 2025 at 7:18 PM
Reposted by Ben Busby
Our next roundtable explores challenges in clinical testing for #oncology & #raredisease including how to integrate & analyze multi-modal datasets. Register today: hello.dnanexus.com/webinar/inno...

@dcgenomics.bsky.social @labcorp.bsky.social @premalshah.bsky.social @myome.com
February 6, 2025 at 5:46 PM
If you use python — codon (an accelerator) is now fully open source! Check it out here: www.exaloop.io/blog/codon-2...
Codon in 2025: New compiler-optimized NumPy implementation. Switching to an open source license. | Exaloop
Learn more
www.exaloop.io
January 31, 2025 at 1:47 PM
Reposted by Ben Busby
Is it cheating to explore a dataset for things you did not specifically hypothesize when creating it? We discussed this today at the Postdoc Night Science NYC session. It’s not cheating! The point is make discoveries & then test them in day science. Use this night science trick!
Is hypothesis generation a hindrance to Night Science? @itaiyanai.bsky.social and @stearnslab.bsky.social demonstrated how easy we fall into pattern recognition, missing the “Gorilla” in our own data. Today’s seminar was all about identifying new strategies to stay curious about our own data.
January 31, 2025 at 2:51 AM
Reposted by Ben Busby
In #Diagnostics news, Natera $NTRA MRD study demonstrates potential to resurrect failed adjuvant drugs (celecoxib, an NSAID drug) for people with stage III colon cancer. Researchers used Signatera testing with a 16 targets personalized panel.
January 28, 2025 at 9:14 AM
Reposted by Ben Busby
“We are boldly moving towards a future where fast, affordable, and accurate integrated #multiomics measurements from the same sample and the same instrument become the new standard.”

🧬 Read our CEO Molly He’s perspective on what 2025 has in store for the NGS industry in GEN: bit.ly/4acTn6e
2025 Trends: NGS
This dynamic field has seen tremendous change in recent years. Leaders share their perspectives on what trends we can expect in 2025.
bit.ly
January 27, 2025 at 5:59 PM
A Quantitative Proteome Map of the Human Body: Cell www.cell.com/cell/fulltex...
A Quantitative Proteome Map of the Human Body
Proteomics analysis across human tissues from the GTeX resource reveals insight into tissue-specific pathways and phenotypes arising from genetic diseases.
www.cell.com
January 27, 2025 at 9:52 AM
Reposted by Ben Busby
So my kids have been going through their old things like books and toys and I have a collection of very very lightly used stuffed animals I want to donate somewhere.

Anyone know of a place in the Davis/Sacramento area that takes very lightly used stuffed animals?
January 18, 2025 at 8:39 PM
Reposted by Ben Busby
Hackathon! Register by 2/15: guides.library.cmu.edu/hackathon

"Machine learning and AI approaches to multimodal problems in computational biology."

March 3-5. Hosted by CMU Libraries, @dnanexus.bsky.social + @dcgenomics.bsky.social at @carnegiemellon.bsky.social in PGH (virtual option available)
January 16, 2025 at 6:23 PM
Reposted by Ben Busby
TFBSFootprinter: a multiomics tool for prediction of transcription factor binding sites in vertebrate species https://www.biorxiv.org/content/10.1101/2025.01.09.632105v1
January 12, 2025 at 9:47 AM
Reposted by Ben Busby
I wrote a short post on writing code in unfamiliar territory with AI. I used Claude to build a Chrome extension to add a post-to-Bluesky button on bioRxiv. I've never written Javascript or a Chrome extension before. It took 5 minutes. doi.org/10.59350/rwc...
January 12, 2025 at 2:39 PM
Reposted by Ben Busby
🌱 Don’t miss our workshop at PAG 2025! Dr. Elinor Karlsson of the Broad Institute will share how AVITI™ & Trinity™ 
#sequencing unlocks novel insights into clonal hematopoiesis in at-risk dogs, including those exposed to the 2023 East Palestine, Ohio derailment. bit.ly/3DQogkC
January 9, 2025 at 8:04 PM
Reposted by Ben Busby
TIL 0.0.0.0 is the EC number for "spontaneous reaction."
www.brenda-enzymes.org/all_enzymes....
All enzymes - BRENDA Enzyme Database
BRENDA - The Comprehensive Enzyme Information System
www.brenda-enzymes.org
January 8, 2025 at 11:03 PM
Reposted by Ben Busby
An incredible opportunity for the right person:

The Santa Fe Institute is seeking applications for full-time resident faculty positions at all academic levels

For me, this has been the best possible job ever.

More info here: santafe.edu/about/jobs/r...
sfiscience
SFI seeks applications for full-time, 12-month resident faculty positions at all academic levels.
santafe.edu
January 8, 2025 at 7:39 PM
Reposted by Ben Busby
We’re looking forward to next week’s J.P. Morgan Healthcare Conference in SF! Our CEO Molly He, CTO Michael Previte, and CFO Logan Zinser are presenting 📅 8:30 am on Monday, January 13, recapping our busy 2024 and sharing our plans for 2025. bit.ly/4j9lozv

#JPM25
January 8, 2025 at 6:31 PM
Reposted by Ben Busby
In #CancerDx news, Natera's $NTRA Oncology test volumes rise up considerably in 2024. Signatera's growth outpacing early trailblazers like Foundation Medicine
January 9, 2025 at 6:47 AM
Reposted by Ben Busby
UCLA QCBIO is looking for its next director! Please consider applying! recruit.apo.ucla.edu/JPF10007
Director, Institute for Quantitative and Computational Biosciences
University of California, Los Angeles is hiring. Apply now!
recruit.apo.ucla.edu
January 6, 2025 at 11:35 PM
Reposted by Ben Busby
Catalyzing computational biology research at an academic institute through an interest network https://www.biorxiv.org/content/10.1101/2025.01.05.631403v1
January 7, 2025 at 8:47 AM
Reposted by Ben Busby
🧪 A JAMA Oncology study highlights Deep-IO AI as a superior predictor for lung cancer immunotherapy response, surpassing traditional markers like PD-L1. Experts see it as a step toward personalized treatment. 🩺🖥️ #MLSky
AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC
Score based on pathology images an independent predictor of PFS, OS
www.medpagetoday.com
January 3, 2025 at 5:00 PM